Kymera Therapeutics Inc’s (NASDAQ:KYMR) Forecasted Growth Is -13.3% Or More
In last trading session, Kymera Therapeutics Inc (NASDAQ:KYMR) saw 1.32 million shares changing hands with its beta currently measuring 2.07. Company’s recent per share price